DLA Piper advises sellers of Insife

nyhed
11 apr 2024
Category
Sager

DLA Piper has advised the sellers of the sale of Insife ApS to Qinecsa Solutions. Insife is a well-established software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms with offices in Denmark, UK, USA, Croatia, Germany, Switzerland and India.

Insife is a globally present pharmacovigilance software, technology, and consultancy company that delivers innovation, insights and solutions to pharmaceutical companies and regulatory agencies across the world. The industry-respected HALOPV platform is considered a safety database with multivigilance capabilities and more, as it covers the end-to-end management of PV processes. HALOPV is available as an enterprise-grade technology, as well as in a multi-tenant SaaS offering for cost-effective uses. In addition, Insife’s global regulatory intelligence club for pharmacovigilance (GRIP) club is a unique combination of technology, multi-sourced intelligence and networking, specifically for pharmacovigilance professionals involved in identifying, assessing and implementing requirements.

The acquisition of Insife by Qinecsa represents a strategic move to further strengthen Qinecsa's position as the providing leader of pharmacovigilance solutions, and technologies.

"We are excited about the opportunities that lie ahead as an entity within Qinecsa Solutions," said Martin Holm-Petersen, CEO of Insife. "Joining forces with Qinecsa is a strategic move for the company, its people, and customers. We will leverage the platform to expand our global footprint and better support our clients with HALOPV in combination with Qinecsa’s best-of-breed technology solutions and services for all areas and life cycles of drugs. Together, we will be able to underline on our position as the number one technology provider for pharmacovigilance, expand our reach and capabilities, while driving positive outcomes for the pharmaceutical industry."

Qinecsa Solutions is a portfolio company of Stanley Capital Partners.

Read more about the transaction in Insife’s press release.

The transaction was driven by a team lead by Martin Lavesen, Christoffer Tolstrup, Oliver William Forrester and Stefan Westh Wiencken.